Cargando…

In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012

Sarcoidosis is a multisystem disease with an unpredictable and sometimes fatal course while the underlying pathomechanism is still unclear. Reasons of the increasing hospitalization rate and mortality in the United States remain in dispute but incriminated are a number of distinct comorbidities and...

Descripción completa

Detalles Bibliográficos
Autores principales: Pohle, Susanne, Baty, Florent, Brutsche, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795542/
https://www.ncbi.nlm.nih.gov/pubmed/26987059
http://dx.doi.org/10.1371/journal.pone.0151940
_version_ 1782421618237112320
author Pohle, Susanne
Baty, Florent
Brutsche, Martin
author_facet Pohle, Susanne
Baty, Florent
Brutsche, Martin
author_sort Pohle, Susanne
collection PubMed
description Sarcoidosis is a multisystem disease with an unpredictable and sometimes fatal course while the underlying pathomechanism is still unclear. Reasons of the increasing hospitalization rate and mortality in the United States remain in dispute but incriminated are a number of distinct comorbidities and risk factors as well as the application of more aggressive therapeutic agents. Studies reflecting the recent development in central Europe are lacking. Our aim was to investigate the recent mortality and hospitalization rates as well as the underlying comorbidities of hospitalized sarcoidosis patients in Switzerland. In this longitudinal, nested case-control study, a nation-wide database provided by the Swiss Federal Office for Statistics enclosing every hospital entry covering the years 2002–2012 (n = 15,627,573) was analyzed. There were 8,385 cases with a diagnosis of sarcoidosis representing 0.054% (8,385 / 15,627,573) of all hospitalizations in Switzerland. These cases were compared with age- and sex-matched controls without the diagnosis of sarcoidosis. Hospitalization and mortality rates in Switzerland remained stable over the observed time period. Comorbidity analysis revealed that sarcoidosis patients had significantly higher medication-related comorbidities compared to matched controls, probably due to systemic corticosteroids and immunosuppressive therapy. Sarcoidosis patients were also more frequently re-hospitalized (median annual hospitalization rate 0.28 [IQR 0.15-0.65] vs. 0.19 [IQR 0.13-0.36] per year; p < 0.001), had a longer hospital stay (6 [IQR 2-13] vs. 4 [IQR 1-8] days; p < 0.001), had more comorbidities (4 [IQR 2-7] vs. 2 [IQR 1-5]; p < 0.001), and had a significantly higher in-hospital mortality (2.6% [95% CI 2.3%-2.9%] vs. 1.8% [95% CI 1.5%-2.1%] (p < 0.001). A worse outcome was observed among sarcoidosis patients having co-occurrence of associated respiratory diseases. Moreover, age was an important risk factor for re-hospitalization.
format Online
Article
Text
id pubmed-4795542
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47955422016-03-23 In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012 Pohle, Susanne Baty, Florent Brutsche, Martin PLoS One Research Article Sarcoidosis is a multisystem disease with an unpredictable and sometimes fatal course while the underlying pathomechanism is still unclear. Reasons of the increasing hospitalization rate and mortality in the United States remain in dispute but incriminated are a number of distinct comorbidities and risk factors as well as the application of more aggressive therapeutic agents. Studies reflecting the recent development in central Europe are lacking. Our aim was to investigate the recent mortality and hospitalization rates as well as the underlying comorbidities of hospitalized sarcoidosis patients in Switzerland. In this longitudinal, nested case-control study, a nation-wide database provided by the Swiss Federal Office for Statistics enclosing every hospital entry covering the years 2002–2012 (n = 15,627,573) was analyzed. There were 8,385 cases with a diagnosis of sarcoidosis representing 0.054% (8,385 / 15,627,573) of all hospitalizations in Switzerland. These cases were compared with age- and sex-matched controls without the diagnosis of sarcoidosis. Hospitalization and mortality rates in Switzerland remained stable over the observed time period. Comorbidity analysis revealed that sarcoidosis patients had significantly higher medication-related comorbidities compared to matched controls, probably due to systemic corticosteroids and immunosuppressive therapy. Sarcoidosis patients were also more frequently re-hospitalized (median annual hospitalization rate 0.28 [IQR 0.15-0.65] vs. 0.19 [IQR 0.13-0.36] per year; p < 0.001), had a longer hospital stay (6 [IQR 2-13] vs. 4 [IQR 1-8] days; p < 0.001), had more comorbidities (4 [IQR 2-7] vs. 2 [IQR 1-5]; p < 0.001), and had a significantly higher in-hospital mortality (2.6% [95% CI 2.3%-2.9%] vs. 1.8% [95% CI 1.5%-2.1%] (p < 0.001). A worse outcome was observed among sarcoidosis patients having co-occurrence of associated respiratory diseases. Moreover, age was an important risk factor for re-hospitalization. Public Library of Science 2016-03-17 /pmc/articles/PMC4795542/ /pubmed/26987059 http://dx.doi.org/10.1371/journal.pone.0151940 Text en © 2016 Pohle et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Pohle, Susanne
Baty, Florent
Brutsche, Martin
In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012
title In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012
title_full In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012
title_fullStr In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012
title_full_unstemmed In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012
title_short In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012
title_sort in-hospital disease burden of sarcoidosis in switzerland from 2002 to 2012
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795542/
https://www.ncbi.nlm.nih.gov/pubmed/26987059
http://dx.doi.org/10.1371/journal.pone.0151940
work_keys_str_mv AT pohlesusanne inhospitaldiseaseburdenofsarcoidosisinswitzerlandfrom2002to2012
AT batyflorent inhospitaldiseaseburdenofsarcoidosisinswitzerlandfrom2002to2012
AT brutschemartin inhospitaldiseaseburdenofsarcoidosisinswitzerlandfrom2002to2012